Clover Health Files 8-K on Operations and Financials
Ticker: CLOV · Form: 8-K · Filed: Aug 5, 2024 · CIK: 1801170
| Field | Detail |
|---|---|
| Company | Clover Health Investments, Corp. /De (CLOV) |
| Form Type | 8-K |
| Filed Date | Aug 5, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
Related Tickers: CLOV
TL;DR
Clover Health dropped an 8-K, expect financial updates soon.
AI Summary
Clover Health Investments, Corp. filed an 8-K on August 5, 2024, to report on its results of operations and financial condition, and to file financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a formal reporting event.
Why It Matters
This 8-K filing signals that Clover Health is providing updated information regarding its financial performance and operational status to the SEC and the public.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting financial information and does not inherently indicate new risks.
Key Players & Entities
- CLOVER HEALTH INVESTMENTS, CORP. (company) — Registrant
- 0001801170 (company) — Central Index Key
- 001-39252 (company) — SEC File Number
- 981515192 (company) — IRS Employer Identification No.
- 3401 Mallory Lane , Suite 210 Franklin , Tennessee 37067 (company) — Principal Executive Offices Address
- August 5, 2024 (date) — Date of Report
FAQ
What specific financial results or conditions are being reported in this 8-K?
The provided text of the 8-K filing indicates it is for 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not detail the specific financial figures or conditions within the excerpt.
When was this 8-K filing submitted to the SEC?
The filing was submitted on August 5, 2024.
What is the primary purpose of this 8-K filing for Clover Health Investments, Corp.?
The primary purpose is to report on the company's results of operations and financial condition, and to file financial statements and exhibits.
What is Clover Health Investments, Corp.'s principal executive office address?
The principal executive offices are located at 3401 Mallory Lane, Suite 210, Franklin, Tennessee 37067.
Under which section of the Securities Exchange Act of 1934 is this 8-K filed?
This 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 540 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2024-08-05 16:07:24
Key Financial Figures
- $0.0001 — stered Class A Common Stock, par value $0.0001 per share CLOV The NASDAQ Stock Market
Filing Documents
- clov-20240805.htm (8-K) — 28KB
- a6302024-earningsrelease.htm (EX-99.1) — 313KB
- 0001801170-24-000158.txt ( ) — 491KB
- clov-20240805.xsd (EX-101.SCH) — 2KB
- clov-20240805_lab.xml (EX-101.LAB) — 22KB
- clov-20240805_pre.xml (EX-101.PRE) — 13KB
- clov-20240805_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On August 5, 2024, Clover Health Investments, Corp. (the "Company") issued a press release announcing its financial results for the second quarter ended June 30, 2024. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information set forth in this Item 2.02 (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) List of Exhibits Exhibit No. Description 99.1 Press release dated August 5, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Clover Health Investments, Corp. Date: August 5, 2024 By: /s/ Peter Kuipers Name: Peter Kuipers Title: Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)